PDF herunterladen
Klin Monbl Augenheilkd 2005; 222(8): 643-648
DOI: 10.1055/s-2005-858464
Klinische Studie

© Georg Thieme Verlag KG Stuttgart · New York

Vitrektomie beim diabetischen zystoiden Makulaödem - Ergebnisse von 72 Fällen

Vitrectomy for Diabetic Cystoid Macular Edema - Results of 72 CasesT. Aboutable1 , B. Kalvodova1
  • 1Augenklinik, Allgemeines Fakultätskrankenhaus, 1. Medizinische Fakultät der Karlsuniversität in Prag, Tschechien
Weitere Informationen

Publikationsverlauf

Eingegangen: 21.12.2004

Angenommen: 20.5.2005

Publikationsdatum:
23. August 2005 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Hintergrund: Wir analysierten die Befunde und Sehschärfe sowie mögliche Einflussfaktoren nach Vitrektomie bei Patienten mit diabetischem zystoiden Makulaödem. Material und Methoden: In einer prospektiven Studie wurde eine Pars-plana-Vitrektomie bei 62 Patienten mit einem diabetischen zystoiden Makulaödem und insgesamt 72 Augen durchgeführt, bei denen eine Laserkoagulation erfolglos geblieben war. Eine vitreomakuläre Traktion fand sich biomikroskopisch, mittels eines B-Scan-Ultraschalls sowie mittels der optischen Kohärenz-Tomographie bei 21 Augen, 15 Augen wiesen eine komplette hintere Glaskörperabhebung (PVD) auf und 36 Augen eine partielle periphere PVD. Es wurde eine Vitrektomie mit vitreomakulären tangentiellen Auflockerungen und axialen Traktionskräften durchgeführt. Alle Patienten wurden mindestens 6 Monate lang nachbeobachtet. Ergebnisse: Die anatomischen Ergebnisse waren bei 69 von 72 Augen zufriedenstellend (96 %), der postoperative Visus verbesserte sich um zwei und mehr Zeilen bei 45 von 72 Augen (63 %), blieb gleich bei 22 von 72 Augen (31 %) und verschlechterte sich bei 5 von 72 Augen (7 %). Die Verschlechterung war bedingt durch ein zystoides Makulaödem sowie durch extrem große harte Makulaexsudate. Die besten Ergebnisse wurden beim Ödem mit überwiegend traktionellem Charakter beobachtet sowie bei Augen mit einem zystoiden Makulaödem von weniger als 6 Monaten Dauer. Schlussfolgerungen: Die Vitrektomie zur Behandlung des diabetischen zystoiden Makulaödems ist eine effektive Methode, um das Ödem zu reduzieren und um die Sehschärfe zu verbessern. Die Operation war von Nutzen nicht nur bei Augen mit vitreomakulärer Traktion, sondern auch bei Augen mit kompletter PVD. Die Verbesserung der Sehschärfe nach einer Vitrektomie hängt von der Ödemdauer ab, wobei der Operationszeitpunkt den entscheidenden prognostischen Faktor darstellt.

Abstract

Background: We evaluated visual outcomes after vitrectomy for diabetic cystoid macular edema and factors possibly influencing final visual acuity. Materials and Methods: Studied prospectively, pars plana vitrectomy was performed on 72 consecutive eyes of 61 patients with diabetic cystoid macular edema not responsive to laser photocoagulation therapy. Vitreomacular traction was observed on biomicroscopy, B-scan ultrasonography, and optical coherence tomography in 21 eyes, 15 eyes had a complete posterior vitreous detachment (PVD) and 36 eyes had partial peripheral PVD. Vitrectomy with releasing vitreomacular tangential and axial tractional forces was performed. All patients were followed up for at least 6 months. Results: The anatomical results were satisfactory in 69 of 72 eyes (96 %), the final visual acuity improved by 2 or more lines in 45 of 72 eyes (63 %), remained unchanged in 22 of 72 eyes (31 %), and deteriorated after surgery in 5 of 72 eyes (7 %), due to residual cystoid macular edema and massive macular hard exudates. The best results were obtained in edema with tractional predominance and in eyes with a duration of cystoid macular edema shorter than 6 months. Conclusions: Vitrectomy for diabetic cystoid macular edema is an effective procedure for reducing the edema and improving visual acuity. Surgery was beneficial not only in eyes with vitreomacular traction but also in eyes with complete PVD. Visual improvement after vitrectomy is related to duration of edema, therefore the timing of the surgery is an important prognostic factor.

Schlüsselwörter

Diabetisches Makulaödem - makulare Laserkoagulation - Pars-plana-Vitrektomie

Key words

Diabetic macular edema - macular laser photocoagulation - pars plana vitrectomy

Literatur

  • 1 Aiello L P. Clinical implications of vascular endothelial growth factors in proliferative retinopathy.  Curr Opin Ophthalmol. 1997;  8 19-31
    PubMedGoogle Scholar
  • 2 Benz M, Murray T, Dubovy S. et al . Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone.  Arch Ophthalmol. 2003;  121 271-273
    PubMedGoogle Scholar
  • 3 Blankenship G. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study.  Ophthalmology. 1979;  86 69-78
    PubMedGoogle Scholar
  • 4 Bresnick G H. Diabetic maculopathy. A critical review highlighting diffuse macular edema.  Ophthalmology. 1983;  90 1301-1317
    PubMedGoogle Scholar
  • 5 Bresnick G H. Diabetic macular edema: a review.  Ophthalmology. 1986;  93 989-997
    PubMedGoogle Scholar
  • 6 Brooks H L Jr. Macular hole surgery with and without internal limiting membrane peeling.  Ophthalmology. 2000;  107 1939-1949
    CrossrefPubMedGoogle Scholar
  • 7 Collins P D, Connolly D T, Williams T J. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.  Br J Pharmacol. 1993;  109 195-199
    PubMedGoogle Scholar
  • 8 Connolly D T. Vascular permeability factor: a unique regulator of blood vessel function.  J Cell Biochem. 1991;  47 219-223
    CrossrefPubMedGoogle Scholar
  • 9 Early Treatment Diabetic Retinopathy Study Group . Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report No. 1.  Arch Ophthalmol. 1985;  103 1796-1806
    CrossrefPubMedGoogle Scholar
  • 10 Early Treatment Diabetic Retinopathy Study Research Group . Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to flourescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19.  Arch Ophthalmol. 1995;  113 (9) 1144-1155
    PubMedGoogle Scholar
  • 11 Enaida H, Sakamoto T, Hisatomi T. et al . Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes.  Graefe’s Arch Clin Exp Ophthalmol. 2002;  240 (3) 243-246
    PubMedGoogle Scholar
  • 12 Ferris F L, Patz A. Macular oedema. A complication of diabetic retinopathy.  Surv Ophthalmol. 1984;  28 S452-S461
    PubMedGoogle Scholar
  • 13 Gandorfer A, Messmer E M, Ulbig M W. et al . Resolution of diabetic macular oedema after surgical removal of the posterior hyaloid and the inner limiting membrane.  Retina. 2000;  20 126-133
    CrossrefPubMedGoogle Scholar
  • 14 Gandorfer A, Messmer E M, Ulbig M W. et al . Indocyanine green selectively stains the internal limiting membrane.  Am J Ophthalmol. 2001;  131 387-388
    CrossrefPubMedGoogle Scholar
  • 15 Gass J DM. Macular dysfunction caused by retinal vascular disorders. Craven L Stereoscopic atlas of macular diseases: diagnosis and treatment, 3rd edn St. Louis; Mosby 1987: 333-354
    Google Scholar
  • 16 Harbour J W, Smiddy W E, Flynn H W. et al . Vitrectomy for diabetic macular oedema associated with a thickened and taut posterior hyaloid membrane.  Am J Ophthalmol. 1996;  121 405-413
    PubMedGoogle Scholar
  • 17 Haritoglou C, Gandorfer A, Gass C A. et al . The effect of indocyanine-green on functional outcome of macular pucker surgery.  Am J Ophthalmol. 2003;  135 (3) 328-337
    CrossrefPubMedGoogle Scholar
  • 18 Hofman P, Van Blijswijk B C, Gaillard P J. et al . Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.  Arch Ophthalmol. 2001;  119 861-866
    CrossrefPubMedGoogle Scholar
  • 19 Hykin P, Shields C, Shields J. et al . The efficacy of focal laser therapy in radiation-induced macular edema.  Ophthalmology. 1998;  105 1425-1429
    CrossrefPubMedGoogle Scholar
  • 20 Ikeda T, Sato K, Katano T. et al . Attached posterior hyaloid membrane and the pathogenesis of honeycomb cystoid macular oedema in patients with diabetes.  Am J Ophthalmol. 1999;  127 478-479
    CrossrefPubMedGoogle Scholar
  • 21 Ikeda T, Sato K, Katano T. et al . Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes.  Br J Ophthalmol. 1999;  83 2-14
    PubMedGoogle Scholar
  • 22 Ikeda T, Sato K, Katano T. et al . Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.  Retina. 2000;  20 (2) 220-222
    PubMedGoogle Scholar
  • 23 Jonas J, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide.  Br J Ophthalmol. 2003;  87 24-27
    CrossrefPubMedGoogle Scholar
  • 24 Kalvodova B, Zahlava J. Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography.  Cesk Slov Oftalmol. 2002;  58 (4) 224-232
    PubMedGoogle Scholar
  • 25 Klein R, Klein B, Moss S. et al . The Wisconsin Epidemiologic Study of Diabetes. IV. Diabetic macular edema.  Ophthalmology. 1984;  91 1464-1474
    CrossrefPubMedGoogle Scholar
  • 26 Kuhn F, Kiss G, Mester V. et al . Vitrectomy with internal limiting membrane removal for clinically significant macular oedema.  Graefe’s Arch Clin Exp Ophthalmol. 2004;  242 402-408
    PubMedGoogle Scholar
  • 27 Kumagai K, Ogino N, Furukawa M. et al . Internal limiting membrane peeling in vitreous surgery for diabetic macular edema.  Nippon Ganka Gakkai Zasshi. 2002;  106 590-594
    PubMedGoogle Scholar
  • 28 La H eij EC, Hendrikse F, Kessels A G. et al . Vitrectomy results in diabetic macular edema without evident vitreomacular traction.  Graefe’s Arch Clin Exp Ophthalmol. 2001;  239 (4) 264-270
    PubMedGoogle Scholar
  • 29 Lewis H, Abrams G W, Blumenkranz M S. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloid traction.  Ophthalmology. 1992;  99 753-759
    PubMedGoogle Scholar
  • 30 McDonald H R, Schatz H. Grid photocoagulation of diffuse macular edema.  Retina. 1985;  5 65-72
    CrossrefPubMedGoogle Scholar
  • 31 Miller J W, Adamis A P, Shima D T. et al . Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.  Am J Pathol. 1994;  145 574-584
    PubMedGoogle Scholar
  • 32 Moss S E, Klein R, Klein B E. The incidence of vision loss in a diabetic population.  Ophthalmology. 1988;  95 (10) 1340-1348
    CrossrefPubMedGoogle Scholar
  • 33 Nasrallah F P, Jalkh A E, van Coppenrole F. et al . The role of the vitreous in diabetic macular oedema.  Ophthalmology. 1988;  95 1335-1339
    PubMedGoogle Scholar
  • 34 Olk R J. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.  Ophthalmology. 1986;  93 938-950
    PubMedGoogle Scholar
  • 35 Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema.  Am J Ophthalmol. 2000;  129 (4) 487-494
    CrossrefPubMedGoogle Scholar
  • 36 Otani T, Kishi S. A controlled study of vitrectomy for diabetic macular edema.  Am J Ophthalmol. 2002;  134 214-219
    CrossrefPubMedGoogle Scholar
  • 37 Otani T, Kishi S, Marruyama Y. Patterns of diabetic macular oedema with optical coherence tomography.  Am J Ophthalmol. 1999;  127 688-693
    CrossrefPubMedGoogle Scholar
  • 38 Park D, Schatz H, McDonald H. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.  Ophthalmology. 1997;  104 1838-1846
    PubMedGoogle Scholar
  • 39 Pendergast S D. Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid.  Curr Opin Ophthalmol. 1998;  9 71-75
    PubMedGoogle Scholar
  • 40 Pendergast S D, Hassan T S, Williams G A. et al . Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.  Am J Ophthalmol. 2000;  130 (2) 178-186
    CrossrefPubMedGoogle Scholar
  • 41 Radetzky S, Walter P, Fauser S. et al . Visual outcome of patiens with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.  Graefe’s Arch Clin Exp Ophthalmol. 2004;  242 273-278
    PubMedGoogle Scholar
  • 42 Sander B, Larsen M, Engler C. et al . Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.  Br J Ophthalmol. 2002;  86 (3) 316-320
    CrossrefPubMedGoogle Scholar
  • 43 Sato Y, Lee Z, Shimada H. Vitrectomy for diabetic cystoid macular edema.  Jap J Ophthalmol. 2002;  46 315-322
    PubMedGoogle Scholar
  • 44 Schepens C L, Avila M P, Jalkh A E. et al . Role of the vitreous in cystoid macular edema.  Surv Ophthalmol. 1984;  28 (suppl) 499-504
    CrossrefPubMedGoogle Scholar
  • 45 Sippy B D, Engelbrecht N E, Hubbard G B. Indocyanine green effect on cultured human retinal pigment epithelial cells: Implication for macular hole surgery.  Am J Ophthalmol. 2001;  132 433-435
    CrossrefPubMedGoogle Scholar
  • 46 Stefaniotou M, Aspiotis M, Kalogeropoulos C. et al . Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal.  Eur J Ophthalmol. 2004;  14 (2) 137-143
    PubMedGoogle Scholar
  • 47 Stefansson E, Novack R L, Hatchell D L. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion.  Invest Ophthalmol Vis Sci. 1990;  31 284-289
    PubMedGoogle Scholar
  • 48 Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.  Am J Ophthalmol. 1996;  122 258-260
    PubMedGoogle Scholar
  • 49 Takagi H, Otani A, Kiryu J. et al . New surgical approach for removing massive foveal hard exudates in diabetic macular edema.  Ophthalmology. 1999;  106 (2) 249-256; 256 - 257
    CrossrefPubMedGoogle Scholar
  • 50 Takaya K, Suzuki Y, Mizutani H. et al . Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy.  Retina. 2004;  24 (1) 23-29
    PubMedGoogle Scholar
  • 51 Tano Y. Vitrectomy for diabetic macular edema. American Academy of Ophthalmology, Subspecialty day Retina 2000: Management of posterior segment disease 2000; 1: 43-145 (data on CD)
    Google Scholar
  • 52 Vinores S A, Derevjanik N L, Mahlow J. et al . Electron microscopic evidence for the mechanism of blood- retinal barrier breakdown in diabetic rabbits: comparison with magnetic resonance imaging.  Pathol Res Pract. 1998;  194 497-505
    PubMedGoogle Scholar
  • 53 Weinberger A W, Kirchhof B, Mazinani B E. et al . Persistent indocyanine green (ICG) fluorescence 6 weeks after intraocular ICG administration for macular hole surgery.  Graefe’s Arch Clin Exp Ophthalmol. 2001;  239 (5) 388-390
    PubMedGoogle Scholar
  • 54 Yamaguchi Y, Otani T, Kishi S. Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation.  Am J Ophthalmol. 2003;  135 116-118
    CrossrefPubMedGoogle Scholar
  • 55 Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane.  Am J Ophthalmol. 2001;  132 (3) 369-377
    CrossrefPubMedGoogle Scholar
  • 56 Yamamoto T, Hitani K, Tsukahara I. et al . Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.  Am J Ophthalmol. 2003;  135 14-19
    CrossrefPubMedGoogle Scholar
  • 57 Yoon K C, Seo M S. Macular hole after peeling of the internal limiting membrane in diabetic macular edema.  Ophthalmic Surg Lasers Imaging. 2003;  34 (6) 478-479
    PubMedGoogle Scholar

MU Dr. Tarek Aboutable

Augenklinik, Allgemeines Fakultätskrankenhaus

U nemocnice 2

Prag 2, 12808

Tschechien

Telefon: ++ 4 20/6 05 77 05 06

Fax: ++ 4 20/2 24 91 86 50

eMail: tarek.a@seznam.cz

      >